CN110596268B - Separation and detection method for isomers in loratadine racemate - Google Patents

Separation and detection method for isomers in loratadine racemate Download PDF

Info

Publication number
CN110596268B
CN110596268B CN201910891681.8A CN201910891681A CN110596268B CN 110596268 B CN110596268 B CN 110596268B CN 201910891681 A CN201910891681 A CN 201910891681A CN 110596268 B CN110596268 B CN 110596268B
Authority
CN
China
Prior art keywords
racemate
isomers
steps
separating
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910891681.8A
Other languages
Chinese (zh)
Other versions
CN110596268A (en
Inventor
娄艳华
程雪娇
任连泉
余贵菊
崔志刚
王建
杨雪
姜淋洁
王猛
张磊
韩怡
李丽琴
孙珊珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Zhongsheng Challenge Biotechnology Co ltd
Original Assignee
Tianjin Zhongsheng Challenge Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Zhongsheng Challenge Biotechnology Co ltd filed Critical Tianjin Zhongsheng Challenge Biotechnology Co ltd
Priority to CN201910891681.8A priority Critical patent/CN110596268B/en
Publication of CN110596268A publication Critical patent/CN110596268A/en
Application granted granted Critical
Publication of CN110596268B publication Critical patent/CN110596268B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors

Abstract

The invention provides a separation and detection method of isomers in a flurandran racemate, which is carried out by adopting a high performance liquid chromatography, taking amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel as a stationary phase and taking normal hexane and ethanol as a mobile phase. The method can effectively separate and measure the isomers in the fraserpine racemate, and has the advantages of high efficiency, simplicity, high sensitivity, good separation effect and separation degree of 6.681. Provides a detection method for the subsequent development of the S isomer of the fradoramene and the examination of the R isomer of the fradoramene.

Description

Separation and detection method for isomers in loratadine racemate
Technical Field
The invention belongs to the field of pharmaceutical analysis, and particularly relates to a separation and detection method for isomers in a loratadine racemate.
Background
Flurarana, english name: fluralaner, CAS number 864731-61-3, molecular formula C22H17Cl2F6N3O3Molecular weight 556.9, white to pale yellow solid. The structural formula is shown in figure 1. Fluranide belongs to the isoxazoline class of insecticides and acaricides. The medicine composition is used for preventing and treating ectoparasites of animals such as dogs and cats, and the marketed medicine composition is a mixture of R and S configuration, but later further research results show that the S configuration is the main insecticidal active ingredient. At present, no report of isomer determination methods for fradoramene exists in related documents, enterprise standards and pharmacopoeia by inquiring, and the establishment of a separation detection method for isomers in fradoramene racemates is necessary, so that a foundation is established for the subsequent development of S isomers to be marketed and the inspection of R isomers.
Disclosure of Invention
In view of the above, the present invention is directed to a method for separating and detecting isomers of a loratadine racemate, so as to solve the above problems.
In order to achieve the purpose, the technical scheme of the invention is realized as follows:
a separation and detection method of isomers in a flurandran racemate is carried out by adopting a high performance liquid chromatography, taking amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel as a stationary phase, and forming a mobile phase by using normal hexane and ethanol.
Further, the volume ratio of the n-hexane to the ethanol is (58-62): (38-42).
Preferably, the volume ratio of the n-hexane to the ethanol is 60: 40.
further, the flow rate of the mobile phase is 0.8-1.2 ml/min.
Preferably, the flow rate of the mobile phase is 1.0 ml/min.
Further, the detection wavelength of the liquid chromatogram is 200nm-400 nm.
Preferably, the detection wavelength of the liquid chromatography is 265 nm.
Further, the column length of the chromatographic column is 250mm, the diameter of the chromatographic column is 4.6mm, and the particle size of the packing is 5 microns.
Further, the sample amount of the liquid chromatography is 5 to 50. mu.l, preferably 20. mu.l.
A separation and detection method for isomers in a flurandrine racemate comprises the following steps:
(1) taking a proper amount of the fraserpine racemate, adding ethanol to dissolve and dilute the mixture to prepare a sample solution containing about 0.5mg in each 1 ml;
(2) amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel is used as a filler; taking a mixed solution of n-hexane and ethanol with a volume ratio of 60:40 as a mobile phase; setting the flow rate to 1.0ml per minute; the detection wavelength is 265 nm; the sample amount is 20 mul; the column temperature is room temperature;
(3) and (2) injecting 5-20 mu L of the sample solution obtained in the step (1) into a high performance liquid chromatograph (4.6mm multiplied by 250mm, 5 mu m) to finish the separation and detection of isomers in the fraralanine racemate.
Compared with the prior art, the method for separating and detecting the isomers in the fraserpine racemate has the following advantages:
the method can effectively separate and measure the isomers in the fraserpine racemate, and has the advantages of high efficiency, simplicity, high sensitivity, good separation effect and separation degree of 6.681. Provides a detection method for the subsequent development of the S isomer and the subsequent examination of the R isomer.
Drawings
FIG. 1 is a structural formula of frataxin;
FIG. 2 is an HPLC chart of a fraserpine racemate;
FIG. 3 is a graph showing the effect of HPLC separation of a sample solution in the examples;
FIG. 4 is an HPLC chart of Y1 in example;
FIG. 5 is an HPLC chart of Y2 in example.
Detailed Description
Unless defined otherwise, technical terms used in the following examples have the same meanings as commonly understood by one of ordinary skill in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods are conventional methods unless otherwise specified.
The present invention will be described in detail with reference to the following examples and accompanying drawings.
Instrument and reagent
Instruments and reagents Type and specification Manufacturer of the product
High performance liquid chromatograph LC-20AT,SPD-20A,SIL-20A SHIMADZU
Electronic balance ES 225SM-DR Precisa
Chiral chromatographic column AD-H(4.6mm×250mm,5μm) Daicel
Fluralanane racemate 99.21% McIdein Biotech Ltd
N-hexane HPLC Tianjin Chuanpu Wei science and technology Limited
Isopropanol (I-propanol) HPLC XILONG SCIENTIFIC Co.,Ltd.
Ethanol HPLC Tianjin Chuanpu Wei science and technology Limited
Second, method and results
(1) Preparing a sample solution:
taking a proper amount of the fraserpine racemate, preparing a solution with a certain concentration, and carrying out ultraviolet scanning within a wavelength range of 200-400 nm. The absorption of the fraralanin racemate at the wavelength of 265nm is found to be the absorption wavelength of liquid phase detection. The spectrum is shown in FIG. 2.
Taking a proper amount of the fraserpine racemate, adding ethanol to dissolve and dilute the mixture to prepare a sample solution containing about 0.5mg of the fraserpine racemate in 1 ml.
(2) Chromatographic conditions are as follows:
the chromatographic column takes amylose-tris (3, 5-dimethylphenyl carbamate) silica gel as a stationary phase, the detection wavelength is 265nm, a normal hexane-isopropanol system and a normal hexane-ethanol system are respectively used for screening to obtain a chromatogram peak shape obtained by the normal hexane-ethanol system, the chromatogram peak shape is sharp and symmetrical, the ratio of the normal hexane to the ethanol is adjusted to be (60:40), so that the peaks of two enantiomers are respectively 5.157min and 7.811min, the separation degree is 6.681, the result is shown in the following table, the chromatogram is shown in fig. 3, and the left peak in the chromatogram represents R-configuration frauran; the right peak represents the S configuration of frainer.
Figure BDA0002208935220000041
The chromatographic conditions are as follows: amylose-tris (3, 5-dimethylphenylcarbamate) silica gel was used as stationary phase (parameters 4.6mm × 250mm, 5 μm); n-hexane-ethanol (60:40) is used as a mobile phase; the flow rate was 1.0ml per minute; the detection wavelength is 265 nm; the sample amount is 20 mul; the solvent is ethanol; the column temperature was room temperature.
(3) The experimental steps are as follows:
(1) taking a proper amount of the fraserpine racemate, adding ethanol to dissolve and dilute the mixture to prepare a sample solution containing about 0.5mg in each 1 ml;
(2) amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel is used as a filler; taking a mixed solution of n-hexane and ethanol with a volume ratio of 60:40 as a mobile phase; setting the flow rate to 1.0ml per minute; the detection wavelength is 265 nm; the sample amount is 20 mul; the column temperature is room temperature;
(3) and (2) injecting 5-20 mu L of the sample solution obtained in the step (1) into a high performance liquid chromatograph (4.6mm multiplied by 250mm, 5 mu m) to finish the separation and detection of isomers in the fraralanine racemate.
Thirdly, result and analysis:
(1) and (3) durability test:
the flow rates are respectively changed to be 0.8ml/min and 1.2ml/min, the flow phase ratio of n-hexane-ethanol (62:38) and n-hexane-ethanol (58:42) has the wavelength of 263nm and 267nm, the column temperature is 20 ℃ and 30 ℃, the change of the chromatographic conditions only slightly influences the retention time and the peak area of the isomers, the separation degree between the isomers is still more than 2.0, and the durability is good. The durability test can show that the method has small change of the chromatographic conditions determined by the method and small influence on the detection of isomers, and the method has good separation degree and durability on R-configuration frataxin and S-configuration frataxin.
(2) Enantiomers were separated and determined:
the medium-pressure preparation liquid chromatograph is adopted, and the chromatographic column conditions are as follows:
stationary phase: amylose-tris (3, 5-dimethylphenylcarbamate) silica gel;
mobile phase: the volume ratio of the n-hexane to the ethanol is 60: 40;
flow rate: 3-7-ml/min;
sample introduction amount: 5-10 ml;
column temperature: room temperature;
concentration of fluranine racemate: 10-20mg/ml, and ethanol as solvent.
Collecting the fraxidin by stages under the conditions, concentrating and drying to obtain two products Y1 and Y2.
Respectively weighing appropriate amount of Y1 and Y2, dissolving in ethanol, diluting to obtain solution containing 5mg of each 1ml, and measuring optical rotation to obtain YI
Figure BDA0002208935220000051
Is +61.89, i.e. of R configuration, Y2
Figure BDA0002208935220000052
It is-59.03, namely S configuration.
Taking appropriate amount of Y1 and Y2, precisely weighing, dissolving in ethanol, and diluting to obtain solution containing 0.5mg per 1 ml. And (3) performing positioning according to the chromatographic conditions in the step (2). The peak-off time of Y1 and Y2 was 5.288min and 7.910min, respectively. The chromatogram is shown in FIGS. 4-5.
Therefore, the separation and detection method can separate two enantiomers in the fraserpine racemate, and the method establishes a detection method for subsequently developing S isomer and checking R isomer.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (9)

1. A separation and detection method of isomers in a flurandrine racemate is characterized by comprising the following steps: the method is carried out by adopting a high performance liquid chromatography, taking amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel as a stationary phase, and forming a mobile phase by using normal hexane and ethanol;
the volume ratio of the n-hexane to the ethanol is (58-62): (38-42).
2. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the volume ratio of the n-hexane to the ethanol is 60: 40.
3. the method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the flow rate of the mobile phase is 0.8-1.2 ml/min.
4. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the flow rate of the mobile phase was 1.0 ml/min.
5. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the detection wavelength of the liquid chromatogram is 200nm-400 nm.
6. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the detection wavelength of the liquid chromatogram is 265 nm.
7. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the sample amount of the liquid chromatogram is 5-50 μ l.
8. The method for separating and detecting isomers of a frainer racemate according to claim 1, comprising the steps of: the sample size of the liquid chromatography was 20. mu.l.
9. The method for separating and detecting an isomer in a fraserane racemate according to any one of claims 1 to 8, comprising the steps of:
(1) taking a proper amount of the fraserpine racemate, adding ethanol to dissolve and dilute the mixture to prepare a sample solution containing about 0.5mg in each 1 ml;
(2) amylose-tri (3, 5-dimethylphenyl carbamate) bonded silica gel is used as a filler; taking a mixed solution of n-hexane and ethanol with a volume ratio of 60:40 as a mobile phase; setting the flow rate to 1.0ml per minute; the detection wavelength is 265 nm; the sample amount is 20 mul; the column temperature is room temperature;
(3) injecting 5-20 mu L of the sample solution obtained in the step (1) into a high performance liquid chromatograph, wherein the type of a chromatographic column is 4.6mm multiplied by 250mm and 5 mu m;
and completing the separation and detection of isomers in the fraserpine racemate.
CN201910891681.8A 2019-09-20 2019-09-20 Separation and detection method for isomers in loratadine racemate Active CN110596268B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910891681.8A CN110596268B (en) 2019-09-20 2019-09-20 Separation and detection method for isomers in loratadine racemate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910891681.8A CN110596268B (en) 2019-09-20 2019-09-20 Separation and detection method for isomers in loratadine racemate

Publications (2)

Publication Number Publication Date
CN110596268A CN110596268A (en) 2019-12-20
CN110596268B true CN110596268B (en) 2022-04-26

Family

ID=68861748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910891681.8A Active CN110596268B (en) 2019-09-20 2019-09-20 Separation and detection method for isomers in loratadine racemate

Country Status (1)

Country Link
CN (1) CN110596268B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111308002A (en) * 2020-02-24 2020-06-19 丽珠集团新北江制药股份有限公司 Method for detecting isoxazoline insecticide and impurities thereof
CN111307994B (en) * 2020-03-19 2022-11-22 丽珠集团新北江制药股份有限公司 High performance liquid chromatography analysis method of isoxazoline compounds
CN113773269A (en) * 2020-06-09 2021-12-10 海门慧聚药业有限公司 Crystal form of frairana and preparation method thereof
CN113009048B (en) * 2021-04-16 2023-10-13 成都海关技术中心 Method for detecting content of fluororalrana by dispersive solid-phase extraction and liquid chromatography tandem mass spectrometry
CN113030345B (en) * 2021-04-16 2023-10-13 成都海关技术中心 Determination method and application of fluorine Lei Lana residues in animal-derived food
CN113759044B (en) * 2021-09-07 2023-05-23 丽珠集团新北江制药股份有限公司 Method for detecting fluorine Lei Lana starter by reversed-phase HPLC
CN114137111B (en) * 2021-11-25 2023-05-26 丽珠集团新北江制药股份有限公司 Reversed-phase high performance liquid chromatography analysis method for fluororalrana intermediate oxime acid
CN114414684B (en) * 2021-12-31 2023-05-23 丽珠集团新北江制药股份有限公司 Florarana intermediate and detection method of isomer thereof
CN114527205A (en) * 2022-01-21 2022-05-24 石家庄四药有限公司 Method for detecting isomer of 2-tert-butyloxycarbonylamino-N-benzyl-3-methoxypropionamide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107501199A (en) * 2017-08-16 2017-12-22 南京农业大学 The extraction of fluorine thunder Rana monomeric compound and purification process
WO2019076754A1 (en) * 2017-10-18 2019-04-25 Bayer Aktiengesellschaft Active compound combinations having insecticidal/acaricidal properties

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107501199A (en) * 2017-08-16 2017-12-22 南京农业大学 The extraction of fluorine thunder Rana monomeric compound and purification process
WO2019076754A1 (en) * 2017-10-18 2019-04-25 Bayer Aktiengesellschaft Active compound combinations having insecticidal/acaricidal properties

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Catalytic enantioselective synthesis of carboxy-substituted 2-isoxazolines by cascade oxa-Michael-cyclization;Hyo-Jun Lee等;《Org. Biomol. Chem.》;20181231;第16卷;第657-664页 *
The intravenous and oral pharmacokinetics of lotilaner in dogs;Toutain等;《Parasites & Vectors》;20171231;第10卷;第1-8页 *
异噁唑啉及异噁唑烷类化合物在多糖衍生物类柱上的手性拆分;夏立钧等;《色谱》;19980731;第16卷(第4期);第334-335页第2-3节 *

Also Published As

Publication number Publication date
CN110596268A (en) 2019-12-20

Similar Documents

Publication Publication Date Title
CN110596268B (en) Separation and detection method for isomers in loratadine racemate
CN104749269A (en) Method for determining enantiomer impurity in alogliptin crude drug and preparation by virtue of HPLC
CN106596798B (en) Analysis method of related substances in vortioxetine hydrobromide
CN111189947B (en) Analysis method for separating and detecting propane fumarate tenofovir disoproxil isomer
CN113866337B (en) Mass analysis method for separating and measuring oseltamivir phosphate isomer
CN109856255B (en) Analysis method for controlling isomer impurity content of ticagrelor intermediate
Avula et al. Analysis of primaquine and its metabolite carboxyprimaquine in biological samples: enantiomeric separation, method validation and quantification
Lisowska-Kuźmicz et al. New validated HPLC methodology for the determination of (−)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase
CN115097023A (en) High performance liquid chromatography detection method for zolmitamine related substances
CN107271600A (en) The detection method of isomer impurities content in a kind of 4 (3 fluorine benzyloxy) benzaldehydes
CN104730160B (en) A kind of Acetyl Tyrosine and the high-efficiency liquid chromatography method for detecting of optical isomer thereof
CN113917027B (en) Optical isomer separation detection method of avanafil and intermediate thereof
CN115184527B (en) Detection method of heliotropin impurity
CN113899831B (en) Liquid chromatography detection method for tofacitinib citrate starting material
CN117723680B (en) Separation detection method for lobelia hydrochloride impurity
CN113419006B (en) Liquid phase analysis method of aprepitant optical isomer
CN113917030B (en) Analysis method for simultaneously determining tert-butyl rosuvastatin and isomers thereof
CN113834882B (en) Method for detecting flurbiprofen axetil isomer
CN114354788B (en) Method for measuring related substances in Monnpiravir raw material and preparation thereof
CN114076801B (en) Detection method of related substances in lenalidomide
CN109283263A (en) Determination method for Raltitrexed synthesis quality control
COSKUN et al. Chromatographic Applications in Medicine
CN117761200A (en) Detection method for simultaneously detecting flurbiprofen axetil isomer and flurbiprofen isomer
Özcan et al. A new HPLC method for selexipag analysis in pharmaceutical formulation and bulk form
CN115032291A (en) Detection method of atorvastatin calcium intermediate isomer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant